CVRX: CVRx Inc Market Cap to Revenue

Brandmark of CVRx, Inc (CVRX)

Stable demand for consumables is driven by the lifelong cycle of neurostimulators and strict surgical protocols. The historical P/S trend demonstrates how these factors influence physician adoption of the method and the volume of insurance payouts, with the value recorded at 0.30. The uniqueness of the Barostim system guarantees CVRx, Inc. (CVRX) significant pricing power within the hospital segment.

CVRx (CVRX): P/S Multiple from 07/04/2022 to 11/13/2026

Metric breakdowns and analytics for CVRx, Inc (CVRX)

- stock price and consensus target price:
Share Price cvrx.com|CVRX - Analyst Consensus Forecast
- market capitalization information:
Market Valuation CVRx, Inc|CVRX - Real Price to Acquire Entire Company
- book value of equity indicators:
Net Assets per Share CVRx, Inc.|CVRX - Book Capitalization|Market Cap to Net Assets Ratio cvrx.com|CVRX - Cumulative Company Assets
- business debt structure and liquidity details:
Debt to Equity CVRx, Inc.|CVRX - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital CVRx Inc|CVRX - Company Total Debt|Debt to Book Value Ratio CVRx, Inc|CVRX - Company Long-Term Debts|Company Short-Term Loans and Borrowings CVRx, Inc.|Immediate Liquidity cvrx.com
- net income and valuation ratios data:
CVRX - Net Profit|Projected Future Earnings CVRx, Inc.|CVRX - Price to Earnings Ratio|Future Price to Earnings Multiple CVRx Inc.|CVRX - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio CVRx, Inc|CVRX - Operating profit EBITDA|Net earnings per share for the last 12 months CVRx, Inc.|CVRX - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months cvrx.com|CVRX - Earnings per share growth in current year|Expected earnings per share trend next year CVRx, Inc.
- issuer revenue and sales details:
CVRX - Company Sales|Company Revenue Forecast cvrx.com|CVRX - Market Cap to Revenue|Forward Price to Sales CVRx, Inc
Summary company analytics:cvrx.com (CVRX)
Product sample of CVRx Inc

Investors are assessing the stability of CVRx, Inc. (CVRX) through the ratio of market capitalization to annual revenue, which determines the value of each dollar of sales. By analyzing the relationship between valuation and sales volume, one can understand the extent to which the market overvalues the lifetime revenue stream from implantable device maintenance, comparing the current multiple with its historical extremes to identify reversal points and risks.

Competing companies

regeneron.com - Market Cap to Revenue Ratio|P/S Multiple IRTC (iRhythm)|LNTH - Market Cap to Revenue|MLYS: Market Cap to Revenue|Price-to-Revenue Coefficient Heartflow Inc HTFL|KMTS: P/S Multiple|Market Cap to Revenue esperion.com|Market Cap to Revenue AMRN|Price-to-Revenue Ratio AVR|Price-to-Revenue Ratio Tenaya Therapeutics (TNYA)|MIST (Milestone Pharmaceuticals Inc) - Market Capitalization-to-Revenue Ratio|Cardiol Therapeutics Inc. - Market Cap to Revenue|BEAT: Market Cap to Revenue Ratio|Tenax Therapeutics, Inc. - P/S Multiple|Market Capitalization-to-Revenue Ratio ADGM (Adagio Medical Holdings, Inc.)|BCDA: P/S Multiple|Price to Sales Catheter Precision Corporation (VTAK)|ABIO (ARCA Biopharma Inc) - P/S Multiple|P/S Multiple Acasti|Price-to-Revenue Ratio Aerovate Therapeutics, Inc. (AVTE)|VERV (vervetx.com) - Market Capitalization-to-Revenue Ratio|Windtree Therapeutics, Inc. - Market Cap to Revenue